As mentioned earlier, the only confounding factor between treatment groups was age, e.g., insulin-treated subjects died at a significantly younger age than T2DM subjects without insulin treatment (Table 1, P = 0.01). The gene discussed is INS; the disease is type 2 diabetes mellitus.